Pfizer ready to launch RSV vaccines for older adults, pregnant women in US, Europe
PUURS, Belgium March 9 (Reuters) – U.S. drugmaker Pfizer (PFE.N) is ready to launch its respiratory syncytial virus (RSV) vaccine for both older adults and pregnant women in the United States and Europe later this year, executives said on Thursday. Both Pfizer and British drugmaker GSK (GSK.L) have RSV vaccines they hope to launch in the United States and […]